Join this WhatsApp group on the last trading day to profit.
🚀 Yesterday, 48 out of 50 new members made profits ($200,000).
Join my free group to learn how to maximize profits and minimize risk.
📲https://t.co/AkUwWXZcOH
Reply "stocks" to join for free.
$JZXN ripping on news: $60M crypto commitment at $1.50/share. Digital asset treasury strategy now funded.
Next resistance $2.65, support $1.80.
High risk, high beta, all about execution.
$GOOGL will become the most valuable company in the world very soon…
One of its most notable features is the diversified portfolio which includes:
~ Search & Advertisement ($2T)
~ DeepMind ($900B)
~ Google Cloud ($540B)
~ YouTube ($500B)
~ Waymo ($160B)
Not only this, but $GOOGL has assets in:
~ SpaceX (7.5% stake)
~ $ASTS (AST SpaceMobile)
~ $PL (Planet Labs)
~ $ARM (Arm Holdings)
~ $PATH (UiPath)
~ $MTSR (Metsera)
This is just a few of the notable names within Googles portfolio.
If you want to capitalize off the future, $GOOGL is your top pick…
$INTC is basically the $RKLB to SpaceX and is one of my biggest positions.
Everyone knows it will catch up to TSM as the de-facto semi arm of the US government with Nvidia to Apple backing it.
It’s more of a matter of time.
At a $234B MC ( $TSM is $1.5T), ~7X return just for waiting.
Whether it’s in 2 years or 10 years, I strongly believe Intel is one of the rare opportunities in the market where you can invest in the White House and infinite money printer subsidizing the cash burning foundry development.
It’s not winner takes all, the TAM of semis will keep going up, $TSM is a great long, but US hyperscalers from Google to Nvidia would be pressured to use Intel when available.
United States won’t let Intel fail, this is a high conviction long on US policy.
$SHPH
Target Price: $2.00.
The company has acquired https://t.co/D7IWV2vIz3 for $8 million, entering the $3.24 billion AI drug discovery market. Its Utah AI technology, highlighted in January 2026, aims to accelerate radiotherapy development.
$RNTX
Target Price: $1.50
The IPF market is worth over $4 billion; LTI-03 has significant potential in many areas; biomarker data and progress in Phase II clinical trials could drive the stock price up.
$IXHL
Target Price: $0.50
Advancing late-stage development of IHL-42X and clinical/regulatory planning for PSX-001, with cash support of >$70M until 2027. IHL-42X receives FDA Fast Track approval, accelerating the approval process.
$OSTX
Target Price: $2.00
Phase 2b biomarker data showing immune activation distinguishes long-term survivors, potentially strengthening the BLA submission. This signals approval potential and could drive a stock price rebound.
BREAKING: Silver prices drop -8% in minutes briefly after hitting a fresh record high.
The volatility we are seeing in commodities is truly incredible.
$MIGI
Target Price: $6.00
10% shareholder Endeavor Blockchain, LLC purchased 205,000 shares ($917,550) and 182,018 shares ($829,561) in January 2026, demonstrating confidence. The filing of a bankruptcy record related to damage litigation could restore shareholder value.
Heisenberg's Play of the Month (or at least 30 trading days out or so):
$BABA
Look before you slam me, I get it. It's China. I know. But we cannot deny that it's been in this nice, yet volatile uptrend now for almost 2 full years.
And it just seems like $200 is right there for the taking. But I'll be more conservative and say $175-$180 as first PT.
The Bollinger Bands are telling us it is once again as tight as it is ever. Due for a large move and soon. I would hope it be the upside otherwise I'll look like a fool (again).
Name is a creme of the crop China names and I think you just HODL here on out. 12 months ago when it was trading sub $80's I said the same thing. Ignore the naysayers.
And remember this is just for fun.
-Heis
$FHTX
Target Price: $7.00
FHTX raised $50 million at a 30% premium with backing from BVF, Deerfield, and Flagship Pioneering. The funds will advance its R&D pipeline through 2026, including clinical data for FHD-286 and FHD-909.
$RMTI
Target Price: $1.20
In January, 30 new customers were added in the western region due to supply disruptions. A product procurement agreement was renewed with one of the largest dialysis service providers in the United States.
A portfolio involving these 10 picks will dominate & outperform the markets by a far margin in 2026…
1. $ONDS ~ Provides the secure & jam-resistant communication for autonomous drone operations.
2. $ASTS ~ Building the communication layer for space based connectivity.
3. $ZETA ~ AI Powered customer intelligence & marketing automation.
4. $RKLB ~ Building the future of space logistics & infrastructure.
5. $OSCR ~ Tech driven health insurance disrupter.
6. $IREN ~ Low cost, renewable powered data centers.
7. $NBIS ~ AI infrastructure for high performance workloads.
8. $TSLA ~ Autonomy, robotics & energy on an AI platform.
9. $NVO ~ Leader in GLP-1 obesity & diabetes treatments.
10. $EOSE ~ Building long duration energy storage systems.
These stocks will see significant upside this year with plausible life changing gains…
U.S. Secretary of War Pete Hegseth said Electron succeeded because $RKLB chose a difficult mission & built real capability
That same execution model is why Rocket Lab is becoming the second pillar of U.S. access to orbit as demand for reliable, independent launch capacity grows
I’ve said it before, and I’ll say it again…
$ZETA will create millionaires in 2026 on its upcoming breakout.
With $360M in cash, 42% YoY revenue growth, & the CEO loading, $ZETA will squeeze.
$45+ is incoming for $ZETA sooner than many expect.
Save this post for later…
$UPLD
Target Price: $2.00
49 G2 badges, emphasizing customer feedback and leadership, could attract partners. This signifies product recognition and could contribute to revenue growth.
$GENI
Target Price: $13.00
A sports data and technology company that provides real-time data, betting solutions, and media services for sports leagues, media companies, and betting operators.